W
WAVEMAN · COMPANY
IT · Gartner Inc
> Ask across nine datasets ⌘K
LIVE
TEAM-0.32% 13F +439META+2.47% 13F +2,694RCG-2.04% CLUSTERUTHR-4.03% 13F +425CRWV-1.12% 13F +693CRM-0.46% 13F +1,018CVNA+2.74% 13F +794TPL-0.71% 13F +444NET-4.47% 13F +710MSTR-1.35% 13F +526DELL+15.81% 13F +1,203CRWD-5.42% 13F +1,382ANET+2.87% 13F +1,323COIN-1.05% 13F +475TEAM-0.32% 13F +439META+2.47% 13F +2,694RCG-2.04% CLUSTERUTHR-4.03% 13F +425CRWV-1.12% 13F +693CRM-0.46% 13F +1,018CVNA+2.74% 13F +794TPL-0.71% 13F +444NET-4.47% 13F +710MSTR-1.35% 13F +526DELL+15.81% 13F +1,203CRWD-5.42% 13F +1,382ANET+2.87% 13F +1,323COIN-1.05% 13F +475
← ALL COMPANIES

IT

GARTNER INC
PHARMA & BIOTECH · SERVICES-MANAGEMENT SERVICES · CIK 0000749251
CONGRESS · 2FORM 144 · 5☆ WATCH
INSIDER NET · 180D
-$1.2M
open-market buys minus sells, Form 4 codes P and S
INSIDER BUYERS · 180D
0
CONGRESS BUYERS · 1Y
2
FUNDS ADDED · QTR
279
13F, latest reported quarter
REVENUE GROWTH
+3.7%
XBRL, annual
NET MARGIN
11.2%
CONVERSIONS · 180D
12
codes C/M, not in net · $0 priced
SEVEN FACTS, RANKED AGAINST THE SECTOR · RANK IS NOT A FORECAST
INSIDERS
net -$1.2M over 180 days
-$1.2M over 90 days
below 63% of Pharma & Biotech
CONGRESS
2 members bought in the last year
more than 65% of Pharma & Biotech
FUNDS
279 funds added or opened last quarter
more than 93% of Pharma & Biotech
REVENUE
+3.7% year over year
more than 51% of Pharma & Biotech
MARGIN
11.2% net margin
more than 82% of Pharma & Biotech
BUYBACKS
$1.1B repurchased, FY to 2026-06-30
more than 94% of Pharma & Biotech
SHORT
15.3% of shares outstanding short · 7.3 days to cover · settled 2026-07-31
more than 90% of Pharma & Biotech
THE SITUATION · EVERY LINE IS ONE RULE OVER ONE DATASET
Insiders are net sellers: -$1.2M across 4 people in 180 days.
279 funds added or opened positions in the latest 13F quarter, of 652 holders.
2 members of Congress reported buying it this year.
The year, with the filings on it
Total return indexed to 100 over the last 12 months · every marker is a federal filing, placed at its date — hover any marker for the detail
TOTAL 12M RETURN -25.6%
-25.6%12M
-50%-32%-13%+5%2025-092025-102025-122026-032026-052026-072026-09 2025-12-10 · PAGLIUCA STEPHEN G bought $2.3M2025-12-10 · PAGLIUCA STEPHEN G bought $1.9M2025-12-10 · PAGLIUCA STEPHEN G bought $1.8M2025-12-10 · PAGLIUCA STEPHEN G bought $1.3M2025-12-10 · PAGLIUCA STEPHEN G bought $1.3M2025-12-10 · PAGLIUCA STEPHEN G bought $1.1M2026-08-27 · Kranich Robin B sold $644.1K2025-12-10 · PAGLIUCA STEPHEN G bought $346.9K2026-08-10 · Genovese Yvonne sold $229.0K2026-08-07 · Herkes Claire sold $198.1K2026-08-07 · FUCHS ANNE SUTHERLAND sold $158.5K2025-12-03 · Herkes Claire sold $85.0K2025-12-03 · Rinello John J sold $50.5K2026-02-05 · Rinello John J bought $7.7K2026-08-27 · ROBIN B KRANICH filed to sell $644.1K2026-08-24 · AKHIL JAIN filed to sell $141.2K2026-08-10 · ANNE SUTHERLAND FUCHS filed to sell -2026-08-10 · YVONNE GENOVESE filed to sell $229.0K2026-08-07 · CLAIRE L HERKES filed to sell $198.1K
INSIDER BUYINSIDER SELLFORM 144
INDEXED RETURN, DIVIDEND-ADJUSTED — NOT A PRICE CHART · LARGE TRADES DRAWN FIRST WHEN A NAME FILES HEAVILY
Live price
Daily candles from TradingView, on their licence — no filings are marked on this one
WHY THIS NAME IS ON THE DESK
Insiders have filed to sell — before selling.
The record shows a net $1.2M sold by insiders over 180 days, 279 funds added last quarter, 2 Congress member(s) bought in 12 months, $1.2M in planned Form 144 sales. Every figure is a federal filing, dated the day it became public.
Backtest this pattern Open the screener
Same sector, ranked by filing activity
Sector from the SEC's own SIC classification
UTHRCPIXMRNAREGNLLYALNYELFCITRMDGLDNAVRTXNUVL
Insider transactions
Form 4 purchases and sales (codes P and S) — grants, option exercises and preferred conversions excluded

Over the last 180 days, GARTNER INC insiders sold a net $1.2M of stock across 309 Form 4 purchases and sales, with 0 insider(s) buying. Source: SEC Form 4 filings, as of 2026-09-04.

INSIDER
FILED
SHARES
VALUE
Kranich Robin B
EVP & CHRO
SELL
2026-08-27
3,278.0
$644.1K
Genovese Yvonne
EVP, Bus. & Tech. Insights
SELL
2026-08-10
1,205.0
$229.0K
Herkes Claire
EVP, Conferences
SELL
2026-08-07
1,039.0
$198.1K
FUCHS ANNE SUTHERLAND
Director
SELL
2026-08-07
860.0
$158.5K
Rinello John J
SVP, Global Business Sales
BUY
2026-02-05
50.0
$7.7K
309 TRANSACTIONS ON RECORD

Showing the most recent few. Create a free account to see 304 more transactions on record, the cross-source screener and CSV export. We store only your email address, and there is no password to create.

Institutional holders
13F · holdings as of the latest quarter funds have reported
BAMCO INC /NY/
7,601,009.0 sh
$985.2M
Independent Franchise Partners LLP
5,582,962.0 sh
$723.7M
BlackRock, Inc.
5,217,146.0 sh
$676.2M
VANGUARD CAPITAL MANAGEMENT LLC
4,266,702.0 sh
$553.0M
AQR CAPITAL MANAGEMENT LLC
4,175,036.0 sh
$541.2M
SCHEDULE 13D/G
No 5%+ ownership filings
Nobody has crossed 5% with a filing obligation. Absence is a fact here, not missing data.
Planned sales · Form 144
Filed before the sale — intent, not a trade
ROBIN B KRANICH
FILED 2026-08-27
$644.1K
AKHIL JAIN
FILED 2026-08-24
$141.2K
ANNE SUTHERLAND FUCHS
FILED 2026-08-10
-
YVONNE GENOVESE
FILED 2026-08-10
$229.0K
CLAIRE L HERKES
FILED 2026-08-07
$198.1K
Fund concentration
N-PORT · funds ranked by how much of THEMSELVES they put in this stock — the conviction number 13F cannot show
BARON GROWTH FUND
$167.8M POSITION · AS OF 2026-03-31
6.4%
VY(R) BARON GROWTH PORTFOLIO
$9.9M POSITION · AS OF 2026-03-31
4.5%
Baron First Principles ETF
$11.7M POSITION · AS OF 2026-03-31
4.2%
LVIP Baron Growth Opportunities Fund
$24.5M POSITION · AS OF 2026-03-31
3.8%
Baron Partners Fund
$375.7M POSITION · AS OF 2026-03-31
3.6%
Clarkston Fund
$3.5M POSITION · AS OF 2026-03-31
3.6%
SEC N-PORT, MONTHLY WITH A ~60-DAY PUBLIC LAG · FUNDS ≥ $10M · % = SHARE OF THE FUND'S OWN BOOK
Government contracts
USASpending.gov · total award ceilings over the contract's life, including awards won through subsidiaries — not annual revenue
Department Of Veterans Affairs
RESEARCH AND ADVISORY SERVICES · 2022-08-01
$42.9M
FEDERAL AWARDS ≥ $25M IN THE LAST 90 DAYS · MATCHED VIA SAM.GOV PARENT REGISTRY
Executive pay vs shareholder return · Mr. Hall
DEF 14A pay-versus-performance disclosure · both the headline pay and the SEC's mark-to-market figure, beside the return the company delivered and the return of the peer group it chose itself
FY
CEO TOTAL
ACTUALLY PAID
OTHER NEOs AVG
TSR
PEER TSR
2025
$19.2M
-$7.0M
$4.8M
+58%
+30%
2024
$18.4M
$26.0M
$4.8M
+202%
+29%
2023
$16.3M
$40.0M
$4.2M
+182%
+15%
2022
$15.5M
$16.0M
$4.0M
+110%
-15%
2021
$14.1M
$80.4M
$3.7M
+109%
+5%
TAGGED BY THE COMPANY UNDER SEC ITEM 402(v) · RETURN IS CUMULATIVE FROM THE START OF THE DISCLOSURE PERIOD · GREEN WHERE THE COMPANY BEAT ITS OWN PEER GROUP
Fundamentals
Annual figures from XBRL filings · pick a past date to see them exactly as the market knew them then — restatements and all
2025-122024-122023-122022-12
REVENUE$6.5B$6.3B$5.9B$5.5B
GROSS PROFIT$4.5B$4.3B$4.0B$3.8B
OPERATING INCOME$1.0B$1.2B$1.2B$1.1B
NET INCOME$729.0M$1.3B$882.0M$808.0M
EPS (DILUTED)9.6516.0011.089.96
OPERATING CASH FLOW$1.3B$1.5B$1.2B$1.1B
CASH$1.7B$1.9B$1.3B$698.0M
LONG-TERM DEBT$3.0B$2.5B$2.4B$2.5B
BUYBACKS$2.0B$735.4M$606.2M$1.0B
SEC XBRL · FISCAL-YEAR PERIODS · AS KNOWN ON 2026-09-04 · NOBODY ELSE SHOWS FUNDAMENTALS AS OF A PAST DATE
W WAVEMAN

Public filings, honestly analyzed. Official US government sources in one desk — every figure carries the date it was filed, and the methodology is published, backtest included.

SEC FORM 4FORM 13F 13D/GFORM 144XBRL STOCK ACTCONTRACTSFEC CFPBNRC
PRODUCT
DeskBacktester CompaniesAccount
SUPPORT
FAQMethodology Contact
LEGAL
TermsPrivacy Accessibility
© 2026 WAVEMAN · SOURCE: SEC EDGAR & OFFICIAL GOVERNMENT DATA · NOT INVESTMENT ADVICE · CHART BY TRADINGVIEW · UPDATED 2026-09-04 ALL SYSTEMS LIVE FOR MACHINES →